Westerkirk Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Westerkirk Capital's JNJ Position: Q1 2026 in Review
Westerkirk Capital reduced its Johnson & Johnson (JNJ) stake by 2.7% in Q1 2026, selling an estimated $256K and leaving 38,959 shares worth $9.52M. The position accounts for 1.03% of the portfolio, ranked #21.
Westerkirk Capital first reported a position in JNJ in Q2 2025 and has held it in 4 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Westerkirk Capital held 38,959 shares of Johnson & Johnson worth $9.52M as of Q1 2026.
- Westerkirk Capital sold 1,100 Johnson & Johnson shares in Q1 2026, an estimated $256K.
- Johnson & Johnson made up 1.03% of Westerkirk Capital's portfolio in Q1 2026, its #21 holding.
- Westerkirk Capital first reported a position in Johnson & Johnson in Q2 2025 and has held it in 4 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Westerkirk Capital's 13F filing for Q1 2026, filed 14 May 2026.